Laserfiche WebLink
FINAL AGREEMENT 3.25.22 <br />4. Research on novel harm reduction and prevention efforts such as the <br />provision of fentanyl test strips. <br />5. Research on innovative supply-side enforcement efforts such as improved <br />detection of mail -based delivery of synthetic opioids. <br />6. Expanded research on swift/certain/fair models to reduce and deter opioid <br />misuse within criminal justice populations that build upon promising <br />approaches used to address other substances (e.g., Hawaii HOPE and <br />Dakota 24/7). <br />7. Epidemiological surveillance of OUD-related behaviors in critical <br />populations, including individuals entering the criminal justice system, <br />including, but not limited to approaches modeled on the Arrestee Drug <br />Abuse Monitoring ("ADAM") system. <br />8. Qualitative and quantitative research regarding public health risks and <br />harm reduction opportunities within illicit drug markets, including surveys <br />of market participants who sell or distribute illicit opioids. <br />9. Geospatial analysis of access barriers to MAT and their association with <br />treatment engagement and treatment outcomes. <br />E-15 <br />